Richard Ashley - Abbott Laboratories Insider

Abbott Laboratories -- Brazil Stock  

BRL 45.52  0.00  0.00%

Executive VP of Corporate Devel.

Mr. Richard W. Ashley is Executive Vice President Corporationrationrate Development of the Company. His responsibilities include various aspects of corporate strategic planning and business development. Ashley was appointed to his current position in February of 2004. Prior to joining Abbott he was a Senior Director at McKinsey and Company a former Managing Partner of the firm Chicago office and Head of the firm Global Leadership and Organization practice. During his 31 years with McKinsey Ashley consulted with clients in healthcare energy and industrial manufacturing industries across a wide range of business and organizational issues
Age: 71  EVP Since 2004      
224-667-6100  http://www.abbott.com
Ashley is a member of the Executive Committee of the board of directors of Junior Achievement of Chicago and a former member of the Civic Committee of the Commercial Club of Chicago. He is also a member of the American Bar Association and the Wisconsin Bar Association. He earned a Bachelor Degree in Political Science and Master degree in Business Administration from Northwestern University. He also holds a Juris Doctorate from the University of Wisconsin Law School.

Richard Ashley Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.45 % which means that it generated profit of $3.45 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 4.05 % meaning that it generated $4.05 on every $100 dollars invested by stockholders.
The company has accumulated 24.09 B in total debt with debt to equity ratio (D/E) of 75.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbott Laboratories has Current Ratio of 2.88 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Abbott Laboratories manufactures and sells health care solutions worldwide. Abbott Laboratories (ABTT34) is traded on Sao Paolo Stock Exchange in Brazil. It is located in Abbott Park, IL and employs 74,000 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Abbott Laboratories to your portfolio

Top Management

Abbott Laboratories Leadership Team
Scott White, President
Samuel Scott, Director
Deepak Nath, President
Jaime Contreras, President
Roger Bird, President
Nancy McKinstry, Director
Heather Mason, President
James Farrell, Director
J White, President
Phebe Novakovic, Director
JeanYves Pavee, President
Andrew Lane, President
Roxanne Austin, Director
Georges Vos, President
Stephen Fussell, President
Thomas Freyman, EVP
Sally Blount, Director
Daniel Starks, Director
Thomas Frinzi, President
Eric Fain, President
John Capek, EVP
Robert Alpern, Director, Ph.D
Murthy Simhambhatla, President
Miles White, Chairman
Robert Ford, President
Glenn Tilton, Director
Richard Ashley, EVP
Michael Rousseau, President
Edward Liddy, Director
Hubert Allen, EVP
Charles Foltz, President
Brian Yoor, CFO
John Stratton, Director
Joseph Manning, President
Jared Watkin, President
William Osborn, Director
Brian Blaser, EVP
Michael Warmuth, President
Robert Funck, President
Daniel Salvadori, President
W Farrell, Director

Stock Performance

Abbott Laboratories Performance Indicators